NLRP3 and diabetic kidney disease: Moreover, ZGJTYS mitigates diabetic kidney disease progression by suppressing TMAO-mediated apoptotic mechanisms through modulation of the mROS-NLRP3 inflammatory pathway (Yi et al., 2023).